GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
3.470
-0.060 (-1.70%)
Aug 31, 2026, 2:36 PM EDT - Market open

GoodRx Holdings Stock Forecast

Stock Price Forecast

According to 15 analysts polled by S&P Global, GoodRx Holdings stock has a consensus rating of "Hold" and an average price target of $4.03. The average 1-year stock price forecast is 16.14% higher than the current stock price, while the lowest is $2.65 (-23.63%) and the highest is $5.00 (+44.09%).

Price Target: $4.03 (+16.14%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price$2.65$4.03$4.00$5.00
Change-23.63%+16.14%+15.27%+44.09%

Analyst Ratings

The average analyst rating for GoodRx Holdings stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy444444
Buy111111
Hold888888
Sell222222
Strong Sell000000
Total151515151515

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Bank of America Securities
Bank of America Securities
Sell
Maintains
$3.4$2.65
SellMaintains$3.4$2.65-23.63%Aug 26, 2026
Barclays
Barclays
Sell
Maintains
$3$4
SellMaintains$3$4+15.27%Aug 20, 2026
Truist Financial
Truist Financial
Hold
Reiterates
n/a
HoldReiteratesn/an/aAug 14, 2026
UBS
UBS
Hold
Maintains
$2.5$3.75
HoldMaintains$2.5$3.75+8.07%Aug 13, 2026
TD Cowen
TD Cowen
Buy
Reiterates
$4$5
BuyReiterates$4$5+44.09%Aug 11, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
798.75M
from 796.85M
Increased by 0.24%
Revenue Next Year
840.13M
from 798.75M
Increased by 5.18%
EPS This Year
0.30
from 0.35
Decreased by -13.19%
EPS Next Year
0.36
from 0.30
Increased by 17.30%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
745.42M766.55M750.27M792.32M796.85M798.75M
Revenue Growth
35.36%2.84%-2.13%5.61%0.57%0.24%
Gross Profit
698.71M701.48M687.84M744.11M739.26M715.63M
Gross Margin
93.73%91.51%91.68%93.91%92.77%89.59%
Operating Income
13.41M19.80M49.50M86.20M106.20M167.55M
Net Income
-25.25M-32.83M-8.87M16.39M30.44M27.82M
EPS
----0.350.30
EPS Growth
----2.94%-13.19%
Forward PE
267.21167.96186.5627.0418.8511.42
Free Cash Flow
147.80M95.77M113.28M116.77M81.94M123.91M
No. Analysts
-----14
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High805.0M
Avg798.8M
Low790.7M

Revenue Growth

Revenue Growth202620272028
High
1.0%
Avg
0.2%
Low
-0.8%

EPS Forecast

EPS202620272028
High0.34
Avg0.30
Low0.29

EPS Growth

EPS Growth202620272028
High
-2.9%
Avg
-13.2%
Low
-18.5%